Literature DB >> 27987731

Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery.

Zhengfang Tian1, Yi Xu2, Yufang Zhu3.   

Abstract

We developed a potential pH-responsive protein drug delivery system based on aldehyde-functionalized dendritic mesoporous silica nanoparticles (DMSNs-CHO) as nanocarriers. The structure, protein drug loading and release behavior, in vitro cytotoxicity and cell uptake of the DMSNs-CHO nanoparticles were investigated. The results showed that the uniform DMSNs-CHO nanoparticles had an average particle size of 174±17nm and a mesopore size of 7.7nm. Using bovine serum albumin (BSA) as a model protein drug, BSA could be loaded into DMSNs-CHO nanoparticles owing to the formation of imine bonds between aldehyde groups and primary amines of BSA molecules. BSA loading capacity was about 136μg/mg, and BSA release from DMSNs-CHO nanocarriers was dependent on pH environment. Furthermore, the DMSNs-CHO nanoparticles had no cytotoxicity and could be efficiently taken up by cells. Therefore, the DMSNs-CHO nanoparticles would be promising as nanocarriers for pH-responsive delivery of protein drugs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aldehyde functionalization; Controlled release; Drug delivery; Mesoporous silica

Mesh:

Substances:

Year:  2016        PMID: 27987731     DOI: 10.1016/j.msec.2016.10.039

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

Review 1.  Biomedical applications of dendritic fibrous nanosilica (DFNS): recent progress and challenges.

Authors:  Mina Shaban; Mohammad Hasanzadeh
Journal:  RSC Adv       Date:  2020-10-08       Impact factor: 4.036

2.  DDAO Controlled Synthesis of Organo-Modified Silica Nanoparticles with Encapsulated Fluorescent Boron Dipyrrins and Study of Their Uptake by Cancerous Cells.

Authors:  Aleksandr A Goncharenko; Ilya A Tarasyuk; Yuriy S Marfin; Kirill V Grzhegorzhevskii; Albert R Muslimov; Andrey B Bondarenko; Maxim D Lebedev; Ilya A Kuz'min; Artur S Vashurin; Kirill V Lepik; Alexander S Timin; Evgeniy V Rumyantsev
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

Review 3.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

4.  Surface functionality density regulated in situ reduction of nanosilver on hierarchial wrinkled mesoporous silica nanoparticles and their antibacterial activity.

Authors:  Xuejuan Wan; Lisi Wu; Hang Pei; Haoqi Ke; Guanghui Yang; Jiaoning Tang
Journal:  RSC Adv       Date:  2018-05-25       Impact factor: 4.036

5.  Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery.

Authors:  Maria C Llinàs; Gabriel Martínez-Edo; Anna Cascante; Irene Porcar; Salvador Borrós; David Sánchez-García
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Photothermal and adsorption effects of silver selenide nanoparticles modified by different surfactants in nursing care of cancer patients.

Authors:  Xingju Yang; Chen Wang; Xiaoxu Zhang; Yue Wang; Feng Gao; Lixia Sun; Wenli Xu; Changxiu Qiao; Guiqin Zhang
Journal:  Sci Technol Adv Mater       Date:  2020-09-01       Impact factor: 8.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.